![Daniel Bensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Bensen
Gründer bei
TYRA BIOSCIENCES, INC.
Vermögen: 5 Mio $ am 31.05.2026
Profil
Daniel Bensen is the founder of Tyra Biosciences, Inc., founded in 2018, and holds the title of Chief Discovery Officer since 2025.
Former jobs include Principal Scientist at Trius Therapeutics, Inc. from 2007 to 2014, and Head-Immunology & Protein Chemistry at Cidara Therapeutics, Inc. from 2014 to 2018.
Education includes an undergraduate degree from Point Loma Nazarene University and an MBA from USC Marshall School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC 0,25 % | 12.02.2026 | 146.981 ( 0,25 % ) | 5 Mio $ | 31.05.2026 |
Aktive Positionen von Daniel Bensen
| Unternehmen | Position | Beginn |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Gründer | 02.08.2018 |
Ehemalige bekannte Positionen von Daniel Bensen
| Unternehmen | Position | Ende |
|---|---|---|
| CIDARA THERAPEUTICS | Corporate Officer/Principal | 01.11.2018 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Corporate Officer/Principal | 01.02.2014 |
Ausbildung von Daniel Bensen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Point Loma Nazarene University
 Point Loma Nazarene University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
USC Marshall School of Business
 USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
